Stay updated on TAK-861 Study in Narcolepsy Type 2 Clinical Trial
Sign up to get notified when there's something new on the TAK-861 Study in Narcolepsy Type 2 Clinical Trial page.

Latest updates to the TAK-861 Study in Narcolepsy Type 2 Clinical Trial page
- CheckyesterdayChange DetectedAn NIH-wide banner announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology, and the site revision changes from v3.7.1 to v3.7.2. The study page itself still displays a 403 error.SummaryDifference1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check29 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the study record and navigation with a generic error page, effectively preventing access to the trial information on this page.SummaryDifference18%

- Check36 days agoChange DetectedThe page's Revision label was updated from v3.6.6 to v3.7.0, signaling a new version of the page code.SummaryDifference0.0%

- Check50 days agoChange DetectedSite revision updated from v3.6.5 to v3.6.6, indicating a platform upgrade. The update affects the site framework version but does not modify the study details or visible content.SummaryDifference0.0%

- Check71 days agoChange DetectedThe site footer now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4.SummaryDifference0.0%

Stay in the know with updates to TAK-861 Study in Narcolepsy Type 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAK-861 Study in Narcolepsy Type 2 Clinical Trial page.